Global Markets
Evonik (EVK GY) Q1 2026 (EUR): Adj. EBITDA 475mln (exp. 464.1mln); FY Outlook 2-2.2bln (exp. 2.06bln)
News detail
This positive earnings development is driven by both higher sales volumes and higher prices, alongside ongoing cost reductions.
What do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
